|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Petry KU: HPV and cervical cancer. In: HPV
and cervical cancer. Springer; Berlin, Germany: pp. 59–62. 2012
|
|
4
|
Bhatla N, Aoki D, Sharma DN and
Sankaranarayanan R: Cancer of the cervix uteri. Int J Gynaecol
Obstet. 2 (Suppl 143):S22–S36. 2018. View Article : Google Scholar
|
|
5
|
Khiewvan B, Torigian DA, Emamzadehfard S,
Paydary K, Salavati A, Houshmand S, Shamchi SP, Werner TJ, Aydin A,
Roy SG, et al: Update of the role of PET/CT and PET/MRI in the
management of patients with cervical cancer. Hell J Nucl Med.
19:254–268. 2016.PubMed/NCBI
|
|
6
|
Tangjitgamol S, Anderson BO, See HT,
Lertbutsayanukul C, Sirisabya N, Manchana T, Ilancheran A, Lee KM,
Lim SE, Chia YN, et al: Management of endometrial cancer in Asia:
Consensus statement from the asian oncology summit 2009. Lancet
Oncol. 10:1119–1127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huellner MW, Appenzeller P, Kuhn FP,
Husmann L, Pietsch CM, Burger IA, Porto M, Delso G, von Schulthess
GK and Veit-Haibach P: Whole-body nonenhanced PET/MR versus PET/CT
in the staging and restaging of cancers: Preliminary observations.
Radiology. 273:859–869. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Preda L, Conte G, Bonello L, Giannitto C,
Travaini LL, Raimondi S, Summers PE, Mohssen A, Alterio D, Cossu
Rocca M, et al: Combining standardized uptake value of FDG-PET and
apparent diffusion coefficient of DW-MRI improves risk
stratification in head and neck squamous cell carcinoma. Eur
Radiol. 26:4432–4441. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Viswanathan C, Faria S, Devine C, Patnana
M, Sagebiel T, Iyer RB and Bhosale PR:
[18F]-2-Fluoro-2-Deoxy-D-glucose-PET assessment of cervical cancer.
PET Clin. 13:165–177. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grant P, Sakellis C and Jacene HA:
Gynecologic Oncologic Imaging With PET/CT. Semin Nucl Med.
44:461–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakamura K, Joja I, Fukushima C, Haruma T,
Hayashi C, Kusumoto T, Seki N, Hongo A and Hiramatsu Y: The
preoperative SUVmax is superior to ADCmin of
the primary tumour as a predictor of disease recurrence and
survival in patients with endometrial cancer. Eur J Nucl Med Mol
Imaging. 40:52–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Collins CD: PET/CT in oncology: For which
tumours is it the reference standard? Cancer Imaging 7 Spec No A.
S77–S87. 2007. View Article : Google Scholar
|
|
13
|
Ashwin KR and Somashekhar SP: Management
of early stage cervical cancer. Rev Recent Clin Trials. 10:302–308.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kjær A, Loft A, Law I, Berthelsen AK,
Borgwardt L, Löfgren J, Johnbeck CB, Hansen AE, Keller S, Holm S
and Højgaard L: PET/MRI in cancer patients: First experiences and
vision from copenhagen. MAGMA. 26:37–47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Platzek I, Beuthien-Baumann B, Langner J,
Popp M, Schramm G, Ordemann R, Laniado M, Kotzerke J and van den
Hoff J: PET/MR for therapy response evaluation in malignant
lymphoma: Initial experience. MAGMA. 26:49–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Drzezga A, Souvatzoglou M, Eiber M, Beer
AJ, Fürst S, Martinez-Möller A, Nekolla SG, Ziegler S, Ganter C,
Rummeny EJ and Schwaiger M: First clinical experience with
integrated whole-body PET/MR: Comparison to PET/CT in patients with
oncologic diagnoses. J Nucl Med. 53:845–855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Er HÇ, Erden A, Küçük NÖ and Geçim E:
Correlation of minimum apparent diffusion coefficient with maximum
standardized uptake on fluorodeoxyglucose PET-CT in patients with
rectal adenocarcinoma. Diagn Interv Radiol. 20:105–109.
2014.PubMed/NCBI
|
|
18
|
Grueneisen J, Beiderwellen K, Heusch P,
Buderath P, Aktas B, Gratz M, Forsting M, Lauenstein T, Ruhlmann V
and Umutlu L: Correlation of standardized uptake value and apparent
diffusion coefficient in integrated whole-body PET/MRI of primary
and recurrent cervical cancer. PLoS One. 9:e967512014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baba S, Isoda T, Maruoka Y, Kitamura Y,
Sasaki M, Yoshida T and Honda H: Diagnostic and prognostic value of
pretreatment SUV in 18F-FDG/PET in breast cancer: Comparison with
apparent diffusion coefficient from diffusion-weighted MR imaging.
J Nucl Med. 55:736–742. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kurman RJ, Carcangiu ML, Herrington CS and
Young RH: WHO classification of tumours of female reproductive
organs. 4th. IARC; Lyon: 2014
|
|
21
|
Stock RJ, Zaino R, Bundy BN, Askin FB,
Woodward J, Fetter B, Paulson JA, DiSaia PJ and Stehman FB:
Evaluation and comparison of histopathologic grading systems of
epithelial carcinoma of the uterine cervix: Gynecologic Oncology
Group studies. Int J Gynecol Pathol. 13:99–108. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martinez-Möller A, Eiber M, Nekolla SG,
Souvatzoglou M, Drzezga A, Ziegler S, Rummeny EJ, Schwaiger M and
Beer AJ: Workflow and scan protocol considerations for integrated
whole-body PET/MRI in oncology. J Nucl Med. 53:1415–1426. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shih IL, Yen RF, Chen CA, Chen BB, Wei SY,
Chang WC, Sheu BC, Cheng WF, Tseng YH, Chen XJ, et al: Standardized
uptake value and apparent diffusion coefficient of endometrial
cancer evaluated with integrated whole-body PET/MR: Correlation
with pathological prognostic factors. J Magn Reson Imaging.
42:1723–1732. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chung HH, Nam BH, Kim JW, Kang KW, Park
NH, Song YS, Chung JK and Kang SB: Preoperative [18F]FDG
PET/CT maximum standardized uptake value predicts recurrence of
uterine cervical cancer. Eur J Nucl Med Mol Imaging. 37:1467–1473.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hayano K, Miura F, Amano H, Toyota N, Wada
K, Kato K, Sano K, Takeshita K, Aoyagi T, Shuto K, et al:
Correlation of apparent diffusion coefficientmeasured by
diffusionweighted MRI and clinicopathologic features in pancreatic
cancer patients. J Hepatobiliary Pancreat Sci. 20:243–248. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Small W Jr, Strauss JB, Jhingran A, Yashar
CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ,
Mayr NA, et al: ACR Appropriateness Criteria® definitive
therapy for early-stage cervical cancer. Am J Clin Oncol.
35:399–405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kidd EA, Spencer CR, Huettner PC, Siegel
BA, Dehdashti F, Rader JS and Grigsby PW: Cervical cancer histology
and tumor differentiation affect 18F-fluorodeoxyglucose
uptake. Cancer. 115:3548–3554. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh N and Arif S: Histopathologic
parameters of prognosis in cervical cancer-a review. Int J Gynecol
Cancer. 14:741–750. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Razek AA and Nada N: Correlation of
choline/creatine and apparent diffusion coefficient values with the
prognostic parameters of head and neck squamous cell carcinoma. NMR
Biomed. 29:483–489. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jung NY, Kim SH, Kang BJ, Park SY and
Chung MH: The value of primary tumor (18)F-FDG uptake on
preoperative PET/CT for predicting intratumoral lymphatic invasion
and axillary nodal metastasis. Breast Cancer. 23:712–717. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Monteil J, Maubon A, Leobon S, Roux S,
Marin B, Renaudie J, Genet D, Fermeaux V, Aubard Y and
Tubiana-Mathieu N: Lymph node assessment with
18F-FDG-PET and MRI in uterine cervical cancer.
Anticancer Res. 31:3865–3871. 2011.PubMed/NCBI
|
|
32
|
Chen YB, Liao J, Xie R, Chen GL and Chen
G: Discrimination of metastatic from hyperplastic pelvic lymph
nodes in patients with cervical cancer by diffusion-weighted
magnetic resonance imaging. Abdom Imaging. 36:102–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sala E, Rockall AG, Freeman SJ, Mitchell
DG and Reinhold C: The added role of MR imaging in treatment
stratification of patients with gynecologic malignancies: What the
radiologist needs to know. Radiology. 266:717–740. 2013. View Article : Google Scholar : PubMed/NCBI
|
